Society guideline links: Gestational trophoblastic disease

Introduction —

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International Federation of Gynecology and Obstetrics (FIGO): Cancer report – Diagnosis and management of gestational trophoblastic disease, update (2021)

Canada

●Society of Gynecologic Oncology of Canada (GOC)/Society of Obstetricians and Gynaecologists of Canada (SOGC): Joint clinical practice guideline for the management of gestational trophoblastic diseases (2021)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria on first trimester vaginal bleeding (revised 2025)

●Society of Gynecologic Oncology (SGO): Evidenced-based review and recommendation on epidemiology, diagnosis, and treatment of gestational trophoblastic disease (2021)

●ACR: ACR Appropriateness Criteria on gestational trophoblastic disease (2019)

Europe

●European Organisation for Treatment of Trophoblastic Diseases (EOTTD): Practical guidelines for pathological and genetic diagnosis of hydatidiform moles (2024)

●EOTTD: Practical clinical guidelines for treatment and referral of gestational trophoblastic disease (2020)

●European Society for Medical Oncology (ESMO): Clinical practice guidelines on gestational trophoblastic disease – Diagnosis, treatment, and follow-up (2013)